DCE-MRI定量增强参数对乳腺癌分子分型预测的研究进展

Advances in predicting molecular classification of breast cancer by DCE-MRI quantitative enhancement parameters

乳腺癌是一种高度异质的恶性肿瘤,不同分子分型乳腺癌病人在临床治疗方案及药物的选择以及预后评估等方面具有较大的差异。因此如果能够通过影像检查对分子分型进行准确预测,则可以在临床早期提供最佳的治疗方案并进行准确的预后评估,也可以避免病理检查带来的创伤性。就乳腺癌分子分型与影像学定量参数的关系进行综述。

Breast cancer is a highly heterogeneous malignant tumor. The patients with different molecular types of breast cancer have great differences in clinical treatment options, drug selection and prognosis evaluation. Therefore, if molecular typing can be accurately predicted by imaging examination, the best therapeutic regimen and accurate evaluation of prognosis can be provided in the early clinical stage, it also can avoid injury caused by pathological examination. The relationship between molecular typing and imaging quantitative parameters was reviewed.